InSysBio to present posters at ASCPT 2024 Annual Meeting

events
Conference
March 6, 2024

InSysBio announces its participation in the ASCPT 2024 Annual Meeting which is to be held March 27-29, at the Broadmoor in Colorado Springs, CO. Tatiana Karelina, Head of Neurodegenerative Diseases modeling team, and Vladislav Leonov, CYTOCON DB team, will present 4 posters by InSysBio in frames of the Meeting, namely:

Thursday, March 28, 2024 5:00 PM – 6:30 PM MDT:

  • PII-014 "Unraveling IL9 serum distribution patterns: insights from the CYTOCON Database" by Vladislav Leonov, Ekaterina Mogilevskaya, Elita Gerasimuk, Nikolay Pervushin, Nail Gizzatkulov, Oleg Demin
  • PII-220 "Response to lymphocyte depleting and lymphocyte modulating therapies in different populations of patients with multiple sclerosis investigated by Quantitative Systems Pharmacology model" by Tatiana Karelina, Maria Myshkina, Oleg Demin. The poster will be denoted by a Top Poster Ribbon
  • PII-221 "Tetravalency impact on bispecific antibody-achieved receptor occupancy and target downregulation: estimation by translational PK/RO model of CTX8371 antibody" by Veronika Musatova, Oleg Demin, Oleg Demin Jr, Dmitry Shchelokov
  • PII-222 "Validation of a Quantitative Systems Pharmacology model for Chronic Hepatitis B" by Galina Lebedeva1, Alexander Stepanov1, Veronika Musatova2, Oleg Demin1, Loveleena Bansal3, Cibele V. Falkenberg3, Valeriu Damian

Affiliation: (1) InSysBio UK, Edinburgh, UK; (2) InSysBio CY, Paphos, Cyprus; (3) GSK, Collegeville, PA, US

About InSysBio

InSysBio is a group of Quantitative Systems Pharmacology (QSP) companies located in Limassol, Cyprus (INSYSBIO CY Ltd) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry. For more information about InSysBio, its solutions and services, visit www.insysbio.com

 

July 2020
MoTuWeThFrSaSu
  
1
2
3
4
5
6
1. 06 Jul 2020 17:37 InSysBio to announce the launch of its new tool Heta compiler Heta compiler has been published on GitHub as an OpenSource (Moscow-06.07.2020) InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, presents Heta compiler which is a tool for the development of Quantitative Systems Pharmacology and Systems Biology platforms. Particularly, it allows combining modules written in different formats like: Heta language code, Excel sheets, JSON, YAML formatted structures, SBML and transforming them into the dynamic models of different formats.
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
1. 27 Jul 2020 11:45 InSysBio to evolve its Open Source QSP model of COVID-19 InSysBio has presented a new portion of results in the framework of development of COVID-19 QSP model.
2. 27 Jul 2020 16:42 InSysBio to present its posters at AAIC 2020 Virtual Event InSysBio announces its participation in AAIC 2020 Virtual Event. Alzheimer's Association International Conference is held virtually on July 27-31. InSysBio team presents two posters within its frames
28
29
30
31
  
Upcoming Events
10.11
InSysBio to take part in ACoP 2024
06.11
InSysBio to participate in SITC 2024
Tags
Latest News
10.09
InSysBio team to publish the new article in PSPJournal
04.09
InSysBio to launch Immune Response Template version 3.6.3 for QSP modeling
22.02
14th InSysBio’s Annual Internal Scientific Meeting
24.01
InSysBio to present the new Plugin for Sublime Text and Heta compiler Online
07.12
InSysBio to release public beta of fIVE Calculator